Showing 1 posts of 1 posts found.
Supply of two Roche products has been disrupted after an active pharmaceutical ingredient (API) production facility in the US was …
Long-acting therapies set to reshape HIV treatment market
MHRA authorises Lynkuet for hot flushes linked to breast cancer therapy
MHRA approves Romvimza for tenosynovial giant cell tumour
NICE recommends allergy immunotherapy tablets for younger children
Dunbar Pharmaceuticals and IPS Pharma announce distribution agreement